VC DEAL ANALYSIS: Does Trend-Bucking August Signal Boom Year For Venture Financing?
This article was originally published in Clinica
Executive Summary
August may be called the silly season for the news industry but for the medtech sector, last month saw serious money being raised privately by start-ups and growing SMEs.
You may also be interested in...
VC Deals Analysis: How Four Bad Months Can Spoil The Barrel
Another slow month for VC financing deals means total deal value for 2016 to date is now lagging behind that for the same period last year.
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.